Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection
Clinical trial NCT00885820 · COMPLETED
Trial details
- NCT number
- NCT00885820
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2001-09-01
- Primary completion
- 2004-07-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.